29 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... of with Community-Acquired ... fluoroquinolone #IDSA ... #Acquired #Pneumonia ... #Regimen #Management
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
steroids to treat infectious ... Acquired Pneumonia ... SCAP severe community-acquired ... #Pharmacology #Management ... #Treatment #Indications
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
and Management ... Toxic Megacolon, Shock ... post-ABx, but can be community-acquired ... Ileus, Megacolon, Shock ... #diagnosis #management
CAP, HCAP, HAP and VAP - Diagnosis and Treatment

HCAP & CAP – those presenting to the
HAP and VAP - Diagnosis ... and Treatment ... VAP #Pneumonia #Acquired ... #Community #Diagnosis ... #Management #Treatment
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... or been newly diagnosed ... following initial diagnosis ... #Prevention #Treatment ... #management #opportunistic
Common Variable Immunodeficiency (CVID)

What?
CVID: Immunodeficiency disorder with hypogammaglobulinemia -> increased infection risk secondary to impaired B-cell
late adulthood • Diagnosis ... frequent and severe community-acquired ... conditions Diagnosis ... and M panel Management ... #management
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Auto-amplification loop Diagnosis ... Purtilo (XLP) Acquired ... Unknown cause Treatment ... Lymphohistiocytosis #diagnosis ... #management #treatment
Streptococcal Toxic Shock Syndrome (STSS)
Complication of invasive GAS disease characterized by shock & MOF → occurs
50% in nec fasc Diagnostic ... necrosis STSS Treatment ... day 2 + 3 BIDMC Infectious ... Syndrome #STSS #treatment ... #management #diagnosis
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... antifungals are required ... candida #mucosal #IDSA ... #management #opportunistic ... #infections #HIVAIDS
Bacteremia Quick Reference - Treatment Duration

Gram Negative Bacteremia:
 • Avoid: Aminoglycosides and tigecycline
 • Catheters should
Quick Reference - Treatment ... removed in septic shock ... follow up cultures required ... of metastatic infection ... #Management #Duration